THIOREDOXIN SYSTEMS AKTIEBOLAG
556492-7860ActiveDeveloping novel antibiotic targeting bacterial redox systems for AMR.
Biomedical Companytxnsystems.com
Oversigt
- Ukendt
- Medarbejdere
- Ukendt
- Omsætning
- 1995
- Grundlagt
Nøglebeslutningstagere
Mohamad Takwa
Board Member & Business Advisor
@txnsystems.com+46723XXXXXX
Elias S.J. Arnér
CEO
@txnsystems.com
Mikael Lönn
CHAIRMAN OF THE BOARD
@txnsystems.com
Gisela Sitbon
BOARD MEMBER
@txnsystems.com
+8 flere kontakter i Funnelfeedr
Beskrivelse
Thioredoxin Systems AB is a Swedish biomedical company focused on combating antimicrobial resistance (AMR). They are developing EbsArgent™, an innovative antibiotic regimen specifically designed for complicated urinary tract infections (cUTI). This novel treatment targets the bacterial antioxidant r...